Sign in to continue:

Saturday, April 11th, 2026

Author: Minichart

us corporate news

Local Bounti Corporation Announces $15 Million Convertible Note and Warrant Agreement with U.S. Bounti, LLC

Minichart
March 16, 2026

Local Bounti Corporation Enters \$15M Convertible Note & War...

Continue Reading 0
us corporate news

Seer, Inc. Announces Amendment No. 1 to Tax Benefit Preservation Plan in Latest 8-K Filing

Minichart
March 16, 2026

Seer, Inc. Announces Amendment to Tax Benefit Preservation P...

Continue Reading 0
us corporate news

Waters Corporation Completes Reverse Morris Trust Merger with BD’s Biosciences and Diagnostic Solutions: Q1 2026 Financial Statements and Segment Analysis

Minichart
March 16, 2026

Waters Corporation and BD Complete Transformative BDS Busine...

Continue Reading 0
us corporate news

Bitmine Immersion Technologies Achieves $11.5 Billion Crypto Holdings and Becomes Largest Ethereum Treasury with 4.6 Million ETH 14

Minichart
March 16, 2026

Bitmine Immersion Technologies (BMNR) Announces Record ETH H...

Continue Reading 0
us corporate news

Baxter Announces CFO Transition: Joel Grade Departs, Anita Zielinski Named Interim CFO, Reaffirms 2026 Outlook

Minichart
March 16, 2026

Baxter International Announces CFO Transition and Reiterates...

Continue Reading 0
us corporate news

RB Global Receives TSX Approval for $500 Million Share Repurchase Program Starting March 2026

Minichart
March 16, 2026

RB Global Announces \$500 Million Share Repurchase Program w...

Continue Reading 0
us corporate news

Nomadar Corp. Assigns Naming Rights for JP Financial Arena Bahía de Cádiz in Landmark Sponsorship Agreement

Minichart
March 16, 2026

NOMADAR CORP. – Assignment Agreement of Naming Rights & Shar...

Continue Reading 0
us corporate news

Radnostix, Inc. 8-K Filing Details: Company Information, Address, and Contact Data as of March 11, 2026

Minichart
March 16, 2026

Radnostix, Inc. (Formerly International Isotopes Inc.) Annou...

Continue Reading 0
us corporate news

Outlook Therapeutics Faces Substantial Doubt as a Going Concern Amid Funding Shortfall and Ongoing FDA Setbacks for ONS-5010/LYTENAVA 1234567

Minichart
March 16, 2026

Outlook Therapeutics Faces Substantial Going Concern Doubts ...

Continue Reading 0
us corporate news

Telos Corporation Reports 77% Revenue Growth for Q4 2025 and Forecasts Double-Digit Growth in 2026

Minichart
March 16, 2026

Telos Corporation Q4 2025 Earnings: Key Highlights and Inves...

Continue Reading 0